Home › Funds › CANTOR FITZGERALD, L. P. › IMCR

CANTOR FITZGERALD, L. P. position in IMCR

IMMUNOCORE HLDGS PLC · Health Care

CANTOR FITZGERALD, L. P. reported holding 340,100 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q2 2026 13F filing — a position valued at US$10.8M, representing 0.32% of its reported portfolio and ranking #39 among its reported holdings. CANTOR FITZGERALD, L. P. has disclosed IMCR holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)340.10K sh
Reported value held$10.80M
Portfolio Weight0.32%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CANTOR FITZGERALD, L. P.'s IMCR position evolved

CANTOR FITZGERALD, L. P. first disclosed a stake in IMCR in Q2 2024 at 254,027 shares (US$8.6M). The position peaked in Q2 2026 at 340,100 shares, worth US$10.8M. Across 8 filings, CANTOR FITZGERALD, L. P. increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 340,100 shares valued at US$10.8M — an increase of 289,600 shares quarter over quarter.. Notable position changes include a 75% trim in Q2 2025 (shares rose 16% over the following quarter), a 200% increase in Q3 2025 (shares fell 4% over the following quarter), a 573% increase in Q2 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 254.03K $8.61M New
Q3 2024 101.94K $3.17M Reduce
Q1 2025 100.00K $2.97M New
Q2 2025 25.00K $784.53K Reduce
Q3 2025 75.00K $2.72M Add
Q4 2025 50.50K $1.75M Reduce
Q1 2026 50.50K $1.52M Hold
Q2 2026 340.10K $10.80M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMCR and 13F data

IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 32 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$154.6M), Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMCR

All IMCR fund holders →

FAQ

How long has CANTOR FITZGERALD, L. P. held IMCR?

CANTOR FITZGERALD, L. P. has disclosed IMCR holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

What is CANTOR FITZGERALD, L. P.'s current position in IMCR?

As of Q2 2026, CANTOR FITZGERALD, L. P. holds 340.10K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $10.80M, representing 0.32% of its reported portfolio and ranking #39.

Has CANTOR FITZGERALD, L. P. been buying or selling IMCR?

In the latest 13F filing (Q2 2026), CANTOR FITZGERALD, L. P. increased its position in IMCR. The position peaked in Q2 2026 at 340.10K shares.

Which other funds hold IMCR?

Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.